查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598512

轉化再生醫學市場：按產品類型、應用分類 - 2025-2030 年全球預測

Translational Regenerative Medicine Market by Product Type (Cell Based Product, Gene Therapy Product, Tissue Engineered Product), Application (Cardiovascular, Dermatology, Diabetes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年轉化再生醫學市場規模為30.1億美元，預計2024年將達到33.6億美元，複合年成長率為11.48%，2030年將達64.6億美元。

轉化再生醫學是一個旨在透過將基礎科學知識轉化為新的治療方法和醫療程序來彌合實驗室研究和臨床應用之間差距的領域。這個領域至關重要，因為它有可能徹底改變目前難以治療或治療不足的疾病的治療方法，例如神經退化性疾病、心臟病和某些類型的癌症。不斷成長的醫療保健需求、人口老化以及對創新醫療解決方案的需求凸顯了該領域的需求。應用範圍廣泛，包括組織工程、幹細胞治療和生物材料，最終用途包括醫院、診所和研究機構。市場成長的主要因素是技術進步、研發投資的增加以及有利的法律規範。個人化醫療的開發發現了新的商機，這種醫療利用了針對患者的特定治療方法。投資步態分析系統來提高再生治療的準確性具有巨大的潛力。擴大幹細胞和組織生物銀行服務將確保為臨床環境中的快速部署做好準備，並進一步擴大商業機會。然而，該領域面臨可能阻礙成長的挑戰，包括高昂的研發成本、複雜的監管核准以及有關幹細胞使用的倫理問題。透過基因編輯 CRISPR 技術的進步以及設計新方法來降低生產成本，創新可以幫助解決這些限制。生技公司、學術機構和監管機構之間的合作可以培養一個有利於更快臨床採用的生態系統。市場的特色是技術創新快速，倒逼企業不斷創新。透過專注於提高再生醫學治療的擴充性和改進當前的治療提供系統，公司可以實現永續成長。掌握監管變化並投資於特定市場的研究對於克服障礙和利用新興機會至關重要。

主要市場統計
基準年[2023] 30.1億美元
預測年份 [2024] 33.6億美元
預測年份 [2030] 64.6億美元
複合年成長率（%） 11.48%

市場動態：揭示快速發展的轉化再生醫學市場的關鍵市場洞察

供需的動態交互作用正在改變轉化再生醫學市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球慢性病和遺傳相關疾病的盛行率不斷上升
    • 對治療癌症、自閉症等的幹細胞療法的需求不斷成長。
    • 老年人口的增加以及隨之而來的疾病的增加
  • 市場限制因素
    • 治療成本上升和手術效率低下
  • 市場機會
    • 利用再生醫學繼續研究器官移植
    • 優惠的報銷政策和技術進步
  • 市場挑戰
    • 由於嚴格的法規和批准而必須遵守

波特五力：駕馭轉化再生醫學市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解轉化再生醫學市場的外部影響

外部宏觀環境因素在塑造轉化再生醫學市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解轉化再生醫學市場的競爭狀況

對轉化再生醫學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣轉換再生醫學市場供應商績效評估

FPNV定位矩陣是評估轉化再生醫學市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了轉化再生醫學市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對轉化再生醫學市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地慢性病和遺傳疾病的發生率正在增加
      • 對治療癌症和自閉症等疾病的幹細胞療法的需求不斷成長
      • 人口老化和相關疾病的增加
    • 抑制因素
      • 處理成本高、營運效率低
    • 機會
      • 利用再生醫學進行器官移植的研究正在進行中
      • 優惠的報銷政策和技術進步
    • 任務
      • 嚴格的法規和核准合規義務
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章轉化再生醫學市場：依產品類型

  • 細胞產品
  • 基因治療產品
  • 組織工程產品

第7章轉化再生醫學市場：依應用分類

  • 心血管
  • 皮膚科
  • 糖尿病
  • 神經病學
  • 腫瘤學
  • 整形外科

第8章美洲轉化再生醫學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太轉化再生醫學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲轉化再生醫學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Astellas Pharma Inc.
  • Athersys, Inc.
  • AVITA Medical
  • Axogen Corporation
  • Gamida Cell Ltd.
  • Integra LifeSciences Corporation
  • Isto Biologics
  • Medtronic PLC
  • Mesoblast Ltd.
  • MIMEDX, Inc.
  • Novartis AG
  • Orthofix Medical Inc.
  • Parexel International Corporation
  • Spark Therapeutics, Inc.
  • Vericel Corporation
Product Code: MRR-03168519577F

The Translational Regenerative Medicine Market was valued at USD 3.01 billion in 2023, expected to reach USD 3.36 billion in 2024, and is projected to grow at a CAGR of 11.48%, to USD 6.46 billion by 2030.

Translational Regenerative Medicine is a field that aims to bridge the gap between laboratory research and clinical application by transforming insights from basic science into novel therapies and medical procedures. It is essential due to its potential to revolutionize the treatment of diseases that are currently incurable or inadequately managed, such as neurodegenerative disorders, heart disease, and certain types of cancer. The necessity for this field is underscored by rising healthcare needs, aging populations, and the demand for innovative medical solutions. Its applications are vast, encompassing tissue engineering, stem cell therapy, and biomaterials, with end-use sectors including hospitals, clinics, and research institutions. Market growth is primarily fueled by technological advancements, increased R&D investments, and favorable regulatory frameworks. Emerging opportunities are found in the development of personalized medicine, which leverages patient-specific treatments. Investment in gait analysis systems to enhance the accuracy of regenerative therapies offers significant potential. The expansion of biobanking services for stem cells and tissues adds another layer of commercial opportunity, ensuring readiness for quick deployment in clinical settings. However, the field faces challenges such as high costs of research and development, complex regulatory approvals, and ethical concerns regarding stem cell use that could hinder growth. Innovations could successfully address these limitations through advancements in CRISPR technology for gene editing or by devising new methods to reduce production costs. Collaborations between biotech firms, academic institutions, and regulatory bodies could foster an ecosystem conducive to faster clinical adoption. The market is characterized by rapid technological change, which compels businesses to continuously innovate. Focusing on enhancing the scalability of regenerative medicine therapies and improving current therapeutic delivery systems can position firms for sustained growth. Staying abreast of regulatory changes and investing in market-specific research will be crucial to overcoming obstacles and leveraging burgeoning opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 3.01 billion
Estimated Year [2024] USD 3.36 billion
Forecast Year [2030] USD 6.46 billion
CAGR (%) 11.48%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Translational Regenerative Medicine Market

The Translational Regenerative Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of chronic and genetic related diseases worldwide
    • Upsurge in the demand for stem cell therapy for the treatment of diseases such as cancer and autism
    • Rising geriatric population coupled with associated diseases
  • Market Restraints
    • High cost of the treatment and operational inefficiency
  • Market Opportunities
    • Ongoing research in the organ transplantation with regenerative medicine
    • Favorable reimbursement policies and technological advancements
  • Market Challenges
    • Stringent regulations and compliance mandates for approval

Porter's Five Forces: A Strategic Tool for Navigating the Translational Regenerative Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Translational Regenerative Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Translational Regenerative Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Translational Regenerative Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Translational Regenerative Medicine Market

A detailed market share analysis in the Translational Regenerative Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Translational Regenerative Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Translational Regenerative Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Translational Regenerative Medicine Market

A strategic analysis of the Translational Regenerative Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Translational Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Athersys, Inc., AVITA Medical, Axogen Corporation, Gamida Cell Ltd., Integra LifeSciences Corporation, Isto Biologics, Medtronic PLC, Mesoblast Ltd., MIMEDX, Inc., Novartis AG, Orthofix Medical Inc., Parexel International Corporation, Spark Therapeutics, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Translational Regenerative Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cell Based Product, Gene Therapy Product, and Tissue Engineered Product.
  • Based on Application, market is studied across Cardiovascular, Dermatology, Diabetes, Neurology, Oncology, and Orthopedic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of chronic and genetic related diseases worldwide
      • 5.1.1.2. Upsurge in the demand for stem cell therapy for the treatment of diseases such as cancer and autism
      • 5.1.1.3. Rising geriatric population coupled with associated diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the treatment and operational inefficiency
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research in the organ transplantation with regenerative medicine
      • 5.1.3.2. Favorable reimbursement policies and technological advancements
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and compliance mandates for approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Translational Regenerative Medicine Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cell Based Product
  • 6.3. Gene Therapy Product
  • 6.4. Tissue Engineered Product

7. Translational Regenerative Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular
  • 7.3. Dermatology
  • 7.4. Diabetes
  • 7.5. Neurology
  • 7.6. Oncology
  • 7.7. Orthopedic

8. Americas Translational Regenerative Medicine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Translational Regenerative Medicine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Translational Regenerative Medicine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Astellas Pharma Inc.
  • 2. Athersys, Inc.
  • 3. AVITA Medical
  • 4. Axogen Corporation
  • 5. Gamida Cell Ltd.
  • 6. Integra LifeSciences Corporation
  • 7. Isto Biologics
  • 8. Medtronic PLC
  • 9. Mesoblast Ltd.
  • 10. MIMEDX, Inc.
  • 11. Novartis AG
  • 12. Orthofix Medical Inc.
  • 13. Parexel International Corporation
  • 14. Spark Therapeutics, Inc.
  • 15. Vericel Corporation

LIST OF FIGURES

  • FIGURE 1. TRANSLATIONAL REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. TRANSLATIONAL REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSLATIONAL REGENERATIVE MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL BASED PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE ENGINEERED PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. TRANSLATIONAL REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023